MedPath

Clinical Effectiveness of Polymethoxy Flavones Solid Dispersion as a Dressing Material for Palatal Grafts Donor Sites

Not Applicable
Not yet recruiting
Conditions
Soft Tissue Infections
Gingival Recession
Interventions
Drug: hydroxylate flavones solid dispersion application
Other: Placebo
Registration Number
NCT05814003
Lead Sponsor
Assiut University
Brief Summary

Free gingival grafting surgeries require palatal grafts harvesting from the patient own palates . The donor sites pain , infection and retarded healing by secondary intension are the complication .

Detailed Description

After the preparation and characterization of the solid dispersion of hydroxylated methoxy flavones, free gingival grafting surgeries require palatal grafts harvesting from the patient own palates . The donor sites pain , infection and retarded healing by secondary intension are the complications ; the aim of the study is to assess the analgesic , anti inflammatory effects of hydroxylated methoxy flavones.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • insufficient zone of keratinized gingiva recession of the gingiva non smokers free from systemic disorders
Exclusion Criteria
  • smokers insufficient palatal donor sits un realistic expectations

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
hydroxylate flavoneshydroxylate flavones solid dispersion applicationflavonoids mainly derived from citrus peel and have numerous strong biological activities, including anti-inflammatory , antioxidant , antimicrobial , and anticancer
hydroxylate flavonesPlaceboflavonoids mainly derived from citrus peel and have numerous strong biological activities, including anti-inflammatory , antioxidant , antimicrobial , and anticancer
alveogylhydroxylate flavones solid dispersion applicationALVOGYL is a brown fibrous paste which contains per 100 g the following active ingredients : 25.70 g of butamben, 15.80 g of iodoform and 13.70 g of eugenol.
alveogylPlaceboALVOGYL is a brown fibrous paste which contains per 100 g the following active ingredients : 25.70 g of butamben, 15.80 g of iodoform and 13.70 g of eugenol.
stenthydroxylate flavones solid dispersion applicationacrylic resin material used to cover denuded soft tissues
Primary Outcome Measures
NameTimeMethod
post operative pain (VAS scale)first day postoperative to 30 days (days)

VAS scale from 0 no pain to 10 excruciating pain (healing)

Secondary Outcome Measures
NameTimeMethod
Number of analgesic and anti inflammatory pills consumedfirst day postoperative to 30 days (days)

Minimizing the pain and inflammation during healing process post operative swelling

Trial Locations

Locations (1)

Assiut University

🇪🇬

Assiut, Egypt

© Copyright 2025. All Rights Reserved by MedPath